NEW YORK (GenomeWeb) – Rubicon Genomics today announced it has secured $2 million in growth capital financing.

BroadOak Capital Partners led the round, joined by Research Corporation Technologies.

The Ann Arbor, Michigan-based sample prep firm said it will use the proceeds to develop new and existing products, including its ThruPlex Plasma-seq liquid biopsy kit, and to add to its sales and marketing. Among the firm's other products are the ThruPLEX DNA-seq, PicoPLEX DNA-seq, and PicoPLEX WGA Kits.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A new report highlights the potential threats posed by advances in synthetic biology, NPR reports.

A Bloomberg reporter tried to get her genetic data deleted, but found it's not so simple to do.

Johns Hopkins University's Steven Salzberg and his colleagues have come up with a new estimate for the number of human genes, Nature News reports.

In Genome Research this week: study of intra-tumor heterogeneity, workflow resources for EPIGEN-Brazil, and more.